In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Biosite, Cleveland Clinic develop CV disease test

Executive Summary

The Cleveland Clinic Foundation licensed Biosite (protein-based diagnostic tests) diagnostic rights to myeloperoxidase (MPO), a marker of inflammation of the coronary artery wall, an event that could signal a person's risk of heart disease or heart attack.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register